Acceleron Pharma
XLRN
#1821
Rank
ยฃ8.35 B
Marketcap
ยฃ136.64
Share price
0.00%
Change (1 day)
15,051.87%
Change (1 year)

Revenue for Acceleron Pharma (XLRN)

Revenue in 2021 (TTM): ยฃ82.52 Million

According to Acceleron Pharma's latest financial reports the company's current revenue is ยฃ86.19 Million. In 2020 the company made a revenue of ยฃ70.72 Million an increase over the revenue in the year 2019 that were of ยฃ56.56 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acceleron Pharma from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)ยฃ82.52 M16.69%
2020ยฃ70.72 M25.05%
2019ยฃ56.56 M428.85%
2018ยฃ10.69 M3.78%
2017ยฃ10.3 M-51.45%
2016ยฃ21.22 M53.47%
2015ยฃ13.83 M23.68%
2014ยฃ11.18 M-74.43%
2013ยฃ43.74 M275.17%
2012ยฃ11.66 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
ยฃ75.93 B 87,991.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ48.63 B 56,322.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ29.73 B 34,399.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ12.91 B 14,883.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ26.41 M-69.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
ยฃ0.17 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
ยฃ79.45 M-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA